AzTrials
AzTrials

Mandibular FracturesPhase 4InterlockingNCT06939010

3D Interlocking Miniplates in Fixation of Mandibular Fractures in the Mental Foramen Region: A Split-mouth Study

A Phase 4 study testing 3d-interlocking miniplate and Conventional miniplates in people with Mandibular Fractures and Miniplate, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the study aims to compare 3D Interlocking miniplates with conventional miniplates in management of mandibular parasymphyseal fractures both clinically and radiographically. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mandibular Fractures, Miniplate
What is being tested?
3d-interlocking miniplate and Conventional miniplates
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 1 Dec 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients with recent bilateral mandibular fracture located in the mental foramina region.
  • adults without gender predilection who agreed to follow-up,
  • fractures requiring open reduction and internal fixation, and
  • those medically fit for general anesthesia were included

Who cannot join

  • medically compromised patients,
  • fractures with infection,
  • pathological or old fractures,
  • completely edentulous patients,
  • comminuted fractures

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Alexandria University

    Alexandria, Alexandria Governorate, 21523

Other trials in Egypt

About this study

Official title: 3D Interlocking Miniplates Versus Conventional Miniplates in Fixation of Mandibular Fractures in the Mental Foramen Region: A Split-mouth Study

the study aims to compare 3D Interlocking miniplates with conventional miniplates in management of mandibular parasymphyseal fractures both clinically and radiographically.

Read the detailed description

A total of 12 patients with recent bilateral parasymphyseal mandibular fractures were treated with 3D Interlocking miniplates on one side and with conventional two miniplates in the other side. Clinical evaluations were carried at multiple intervals up to 6 weeks postoperatively, with radiographic assessments performed immediately after surgery and at 12 weeks to measure mean bone density at the fracture line

Being tested
3d-interlocking miniplate, Conventional miniplates
Keywords
Mental nerve, conventional miniplates, 3D Interlocking, mandibular parasymphyseal fracture
Medical subject headings
Mandibular Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3d-interlocking miniplateDevice

    3d-interlocking miniplate

  • Conventional miniplatesDevice

    double miniplates in the conventional configuration

Study groups in NCT06939010
Study groupRoleWhat they receive
patient with bilateral fracture in the mental nerve region managed with 3D-interlocking miniplateExperimentalpatient with bilateral fracture in the mental nerve region. one side will be randomly allocated to be managed with 3D-interlocking miniplate
Receives: Device: 3d-interlocking miniplate
patient with bilateral fracture in the mental nerve region managed with conventional miniplatesExperimentalpatient with bilateral fracture in the mental nerve region. one side will be randomly allocated to be managed with conventional miniplates
Receives: Device: Conventional miniplates

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiographic evaluation for the assessment of mean bone density at the fracture line

    Mean bone density at the fracture line was assessed using Cone-Beam Computed Tomography (CBCT) scan in Hounsfield Units (HU)

    Measured: 12 weeks

Secondary outcomes (1)
  1. Clinical evaluation for Intra-fragmentary mobility

    Intra-fragmentary mobility was evaluated by bimanual palpation at the fracture site

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2025
  2. Study start1 Jan 2023
  3. Primary completion1 Aug 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Split-mouth
Masking
Single blind
Who is masked
Investigator
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06939010
Sponsor's protocol ID
3D-Interlocking
Acronym
Interlocking
Status last verified
Apr 2025
First submitted
15 Apr 2025
Last updated
22 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study

Publications

  • Abdelhamed IM, Sweedan AO, Ismail RM, El-Mahallawy Y. Three-dimensional Interlocking versus conventional miniplates for mandibular fractures fixation near the mental foramen: a split-mouth randomized clinical trial. BMC Oral Health. 2026 Mar 29;26(1):709. doi: 10.1186/s12903-026-07799-5.

    PubMed 41906100

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing 3d-interlocking miniplate and Conventional miniplates in people with Mandibular Fractures and Miniplate, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiographic evaluation for the assessment of mean bone density at the fracture line (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06939010, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in